Clinical Trials List
2024-05-21 - 2029-02-22
Phase III
Not yet recruiting1
Recruiting7
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
Daiichi Sankyo Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Seu-Chun Yang Division of General Internal Medicine
- Wu-Chou Su Division of Hematology & Oncology
- 黃怡菁 Division of Hematology & Oncology
- Chien-Chung Lin Division of General Internal Medicine
- Shang-Yin Wu Division of Hematology & Oncology
- 鍾秉軒 Division of Hematology & Oncology
- 蔡政軒 Division of General Internal Medicine
- Yu-Min Yeh Division of Hematology & Oncology
- Chin-Wei Kuo Division of General Internal Medicine
- Wen-Pin Su Division of Hematology & Oncology
- 黃怡璇 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳鴻仁 Division of Thoracic Medicine
- Chih-Yen Tu Division of Thoracic Medicine
- Yu-Chao Lin Division of General Internal Medicine
- Chia-Hsiang Li Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 趙恒勝 Division of Thoracic Medicine
- YEN-HAN TSENG Division of Thoracic Medicine
- 廖映庭 Division of Thoracic Medicine
- 蕭慈慧 Division of Thoracic Medicine
- Chia-I Shen Division of Thoracic Medicine
- Yung-Hung Luo Division of Thoracic Medicine
- 張毓帆 Division of Ophthalmology
- Yuh-Min Chen Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 李柏昕 Division of Thoracic Medicine
- YEN-HSIANG HUANG Division of Thoracic Medicine
- KUO-HSUAN HSU Division of Thoracic Medicine
- JENG-SEN TSENG Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Inn-Wen Chong Division of Thoracic Medicine
- Chih-Jen Yang Division of Thoracic Medicine
- 莊政皓 Division of Thoracic Medicine
- 李玫萱 Division of Thoracic Medicine
- 郭家佑 Division of Thoracic Medicine
- Ying-Ming Tsai Tsai Division of Thoracic Medicine
- KUAN-LI WU Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳教恩 Division of Hematology & Oncology
- Chih-Hung Chen Division of Hematology & Oncology
- 枋岳甫 Division of Hematology & Oncology
- 黃宗禎 Division of Hematology & Oncology
- Chih-Hsi Kuo Division of Hematology & Oncology
- 邱立忠 Division of Hematology & Oncology
- Chien-Ying Liu Division of Hematology & Oncology
- Ping-Chih Hsu Division of Hematology & Oncology
- 林定佑 Division of Hematology & Oncology
- 柯皓文 Division of Hematology & Oncology
- Chih-Liang Wang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chia-Chi Lin Division of Hematology & Oncology
- 吳尚俊 Division of General Internal Medicine
- 黃得瑞 Division of Hematology & Oncology
- 郭柏邑 Division of Ophthalmology
- 林宗哲 Division of Hematology & Oncology
- YEN-TING LIN Division of General Internal Medicine
- 廖斌志 Division of Hematology & Oncology
- JIN-YUAN SHIH Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Kai-Ling Lee Division of Thoracic Medicine
- Pai-Chien Chou Division of Thoracic Medicine
- Shang-Fu Hsu Division of Thoracic Medicine
- Shih-Hsin Hsiao Division of Thoracic Medicine
- Chun-Liang Chou Division of Thoracic Medicine
- Chi-Li Chung Division of Thoracic Medicine
- Mei-Chuan Chen Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
27 participants
-
Global
540 participants
